{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Keen On America","title":"Episode 2325: Charles Piller on Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer's","html":"","width":"100%","height":180,"duration":2164,"description":"More than 6 million Americans now suffer from Alzheimer’s Disease. So the stakes in find a cure for this neurological illness are huge. Too large, in fact, for some fraudulent American medical researchers. As the investigative science reporter Charles Piller reveals in DOCTORED, there has been considerable fraud, some of it outright criminal, in Alzheimer’s research in the United States. Piller’s key finding, discovered through brave whistleblowers like Vanderbilt’s Dr. Matthew Schrag, is that researchers often doctored images in their studies, either for career advancement or financial gain. Piller emphasizes that while most scientists are honest, institutional oversight has been inadequate in preventing and addressing research misconduct. So I guess Americans should be thankful that the incoming administration has nominated a man of unambiguous moral standing to be the new Secretary of Health and Human Services. I wish.Here are the 5 KEEN ON takeaways from our conversation with Piller:* The Alzheimer's research field has been compromised by instances of scientific misconduct, particularly through the manipulation of research images. While some cases involve financial fraud (like the Cassava Sciences case), most stem from academic pressure to \"publish or perish,\" leading researchers to \"beautify\" or outright falsify their data.* Major scientific institutions (NIH, FDA, universities, and scholarly journals) have failed to properly oversee and investigate potential research misconduct, particularly in image manipulation. Piller argues these institutions need to reform their oversight practices to maintain credibility and advance legitimate research.* The dominance of the \"amyloid hypothesis\" in Alzheimer's research has led to a concentration of funding and attention on one approach, potentially starving other promising research directions. However, new approaches are emerging, including studies of GLP-1 inhibitors (similar to weight loss drugs) and investigations...","thumbnail_url":"https://img.transistorcdn.com/bCpvkYgrorWYCv4ujOodZ7o-xqCKvQH-YHlEI5E7zpw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDM2/MGJjOTYyNjBkYzJi/ZDVhMTUwZDgwMWE3/ZDk3OS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}